Evaluation of Various Factors that Determines the Export of Biopharmaceutical Products: An Empirical Study of Indian Biopharmaceutical Companies
|
|
Author:
|
, GYAN PRAKSH UJALAYAN, SHIBU JOHN, JWAAD AKHTER KHAN, PRERNA SINGH
|
Abstract:
|
Export of goods of any country has greater relevance, especially in the wake of ongoing global trade wars
which have spillover effects to other third world countries across the globe. India enjoys a competitive
advantage in the biopharmaceutical space due to low costs, huge and varied patient pools, availability of many
technologists, and 50 per cent less cost in conducting a clinical trial than that of developed economies. This
paper has made an ardent attempt to critically evaluate seven factors, namely research & development
expenses, net sales, net fixed assets, branding expenses, profit after tax, import of capital goods, and import of
raw materials. The empirical findings of this paper indicate that R&D expenditure, net sales, net fixed assets,
import of capital goods, and import of raw material are the main factors which are influencing the export of
biopharmaceutical products. However, branding expenditure and profit after tax do not have any direct impact
on the export of biopharmaceuticals products in India.
|
Keyword:
|
Biopharmaceuticals, Export, Products, Market, Factors
|
EOI:
|
-
|
DOI:
|
https://doi.org/10.31838/ijpr/2021.13.02.240
|
Download:
|
Request For Article
|
|
|